Maybe it's the U of MN -- though it looks like the

Quote:

---

— Amid warnings that people who get mild symptoms of Covid-19 and recover are driving the spread of the disease, scientists at the University of Minnesota are turning their focus to this particular population. They are launching a new clinical trial to see if an old malaria drug — chloroquine or hydroxychloroquine — is a better post-exposure prophylaxis than the current standard of care: observation. The trial will enroll 1,500 individuals who have had exposure to a Covid-19 case within 3 days, namely either healthcare workers of household contacts. The University of Oxford is planning a similar study with 10,000 participants in May. Clinicians in China and Australia have reported encouraging results treating Covid-19 patients with chloroquine.

---